Genomic perspectives in inter-individual adverse responses following nanomedicine administration: The way forward

Keyphrases

• Nanomedicine 100%
• Adverse Reactions 100%
• Complement Activation 40%
• Polymorphism 20%
• Non-responders 20%
• Genetic Factors 20%
• Health Care Costs 20%
• Adverse Events 20%
• Causal Factors 20%
• Nanotherapeutics 20%
• Intravenous Infusion 20%
• Bronchopulmonary 20%
• Treatment Decisions 20%
• Approval Process 20%
• Molecular Pathways 20%
• Mucocutaneous 20%
• Immunological Mechanisms 20%
• Practice of Medicine 20%
• Risk Assessment 20%
• Drug Hypersensitivity 20%
• Symptom Response 20%
• Overall Cost 20%
• Risk Treatment 20%
• Regulatory Approval 20%
• Innate Immune Genes 20%
• Profiling Test 20%
• Genetic Association Studies 20%
• In Vitro Profiling 20%

Medicine and Dentistry

• Nanomedicine 100%
• Adverse Event 80%
• Infusion 40%
• Complement Activation 40%
• Innate Immunity 20%
• Health Care 20%
• Health Care Cost 20%
• Cardiovascular System 20%
• Medicine 20%
• In Vitro 20%
• Intravenous Drug Administration 20%
• Genetic Association 20%
• DRESS Syndrome 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Nanomedicine 100%
• Adverse Event 80%
• DRESS Syndrome 20%